COPART, INC. vs CVS HEALTH CORPORATION, two Retail stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CPRT and CVS diverge most: on debt / equity, CPRT reads 0.00 and CVS reads 0.77; on net margin, CPRT reads 31.8% and CVS reads 0.7%. The rest of the comparable metrics sit closer together. What CPRT's price implies is a bet that sits within the historical range (whole-company basis). What CVS's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | CPRT | CVS |
|---|---|---|
| Price | $27.32 | $86.18 |
| Market cap | $25.8B | $110.9B |
| Sector | Retail | Retail |
| Stage | Mature | Mature |
| Implied growth (priced in) | +6.6% | — |
| P/E | 17.6 | 22.7 |
| P/B | 2.83 | 1.39 |
| P/S | 5.52 | 0.27 |
| EV/EBITDA | 12.6 | 12.6 |
| Revenue growth | +0.4% | +7.3% |
| Operating margin | 32.0% | 4.4% |
| Net margin | 31.8% | 0.7% |
| Return on equity | 16.3% | 3.7% |
| Return on assets | 14.8% | 1.2% |
| Return on invested capital | 14.7% | 4.4% |
| FCF yield | 4.9% | 10.6% |
| Dividend yield | — | 3.1% |
| Debt / equity | 0.00 | 0.77 |
| Current ratio | 7.91 | 0.87 |
| Altman Z (solvency) | 8.28 | 2.39 |
| Piotroski F (quality) | 6 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.